Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): Study protocol for a randomised controlled trial
(2016)
Journal Article
Tallon, D., Wiles, N., Campbell, J., Chew-Graham, C., Dickens, C., Macleod, U., Peters, T. J., Lewis, G., Anderson, I. M., Gilbody, S., Hollingworth, W., Davies, S., & Kessler, D. (2016). Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): Study protocol for a randomised controlled trial. Trials, 17(1), Article 66. https://doi.org/10.1186/s13063-016-1199-2
© 2016 Tallon et al. Background: People with depression are usually managed in primary care and antidepressants are often the first-line treatment, but only one third of patients respond fully to a single antidepressant. This paper describes the prot... Read More about Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): Study protocol for a randomised controlled trial.